These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8658513)
1. A physiologically based model of chromium kinetics in the rat. O'Flaherty EJ Toxicol Appl Pharmacol; 1996 May; 138(1):54-64. PubMed ID: 8658513 [TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of an intratracheally administered chromium catalyst in rats. Vanoirbeek JA; Hoet PH; Nemery B; Verbeken EK; Haufroid V; Lison D; Dinsdale D J Toxicol Environ Health A; 2003 Feb; 66(4):393-409. PubMed ID: 12554544 [TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349 [TBL] [Abstract][Full Text] [Related]
6. A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humans. O'Flaherty EJ; Kerger BD; Hays SM; Paustenbach DJ Toxicol Sci; 2001 Apr; 60(2):196-213. PubMed ID: 11248132 [TBL] [Abstract][Full Text] [Related]
7. Biomonitoring of chromium(VI) deposited in pulmonary tissues: pilot studies of a magnetic resonance imaging technique in a post-mortem rodent model. Shayer R; Kinchesh P; Raffray M; Kortenkamp A Biomarkers; 2004; 9(1):32-46. PubMed ID: 15204309 [TBL] [Abstract][Full Text] [Related]
8. A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat. Lilly PD; Andersen ME; Ross TM; Pegram RA Toxicol Appl Pharmacol; 1998 Jun; 150(2):205-17. PubMed ID: 9653052 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics. Teeguarden JG; Gearhart J; Clewell HJ; Covington TR; Nong A; Andersen ME J Toxicol Environ Health A; 2007 Sep; 70(18):1515-26. PubMed ID: 17710612 [TBL] [Abstract][Full Text] [Related]
10. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. De Flora S; Iltcheva M; Balansky RM Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865 [TBL] [Abstract][Full Text] [Related]
11. Biliary excretion and distribution of 51Cr(III) and 51Cr(VI) in rats. Cikrt M; Bencko V J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):241-6. PubMed ID: 575148 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and modification of a physiologically based model of lead kinetics using data from a sequential isotope study in cynomolgus monkeys. O'Flaherty EJ; Inskip MJ; Franklin CA; Durbin PW; Manton WI; Baccanale CL Toxicol Appl Pharmacol; 1998 Mar; 149(1):1-16. PubMed ID: 9512721 [TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic model for chromium. O'Flaherty EJ Toxicol Lett; 1993 May; 68(1-2):145-58. PubMed ID: 8516761 [TBL] [Abstract][Full Text] [Related]
14. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure. Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523 [TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Kirman CR; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM; Lin SS; Parker W; Hays SM Chem Biol Interact; 2013 Jun; 204(1):13-27. PubMed ID: 23603453 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
18. Evaluating lead bioavailability data by means of a physiologically based lead kinetic model. Polák J; O'Flaherty EJ; Freeman GB; Johnson JD; Liao SC; Bergstrom PD Fundam Appl Toxicol; 1996 Jan; 29(1):63-70. PubMed ID: 8838640 [TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity studies of 2-Chloronitrobenzene (CAS No. 88-73-3) and 4-Chloronitrobenzene (CAS No. 100-00-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice. Bucher J Toxic Rep Ser; 1993 Jul; 33():1-F25. PubMed ID: 12209191 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]